Breaking News, Financial News

Cambrex

Revenues slipped due to several factors

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Cambrex 2Q10 2Q Revenues: $58.2 million (-2%) 2Q Earnings: $4.8 million (-13%) YTD Revenues: $114.3 million (-5%) YTD Earnings: $6.4 million (-37%) Comments: The drop in revenues was blamed on reduced demand for some large products, a supply chain disruption at a customer’s facility, lower pricing on generic APIs, and a renegotiated contract extension for drug delivery products, resulting in lower pricing. Increased sales volume for controlled substances and generic APIs hel...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters